Lilly and Banner Alzheimer ' s Institute Collaborate on Planned Phase 3 Prevention Trial of Donanemab

INDIANAPOLIS and PHOENIX, July 15, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Banner Alzheimer ' s Institute today announced a strategic research collaboration as part of the planned Phase 3,...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials